Literature DB >> 21992795

Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors.

Sana H Barakat1, Nahla El-Bashir.   

Abstract

The aim of this study was to estimate the prevalence and identify the risk factors of hepatitis C virus (HCV) infection among healthy Egyptian children. A representative random sample of 500 children, age between 6 and 15 years, was selected from 10 schools in Alexandria, Egypt. A questionnaire was used to collect demographic data and potential risk factors, while blood samples were collected and analyzed for antibodies to HCV (anti-HCV). Positive sera were further confirmed by HCV-RNA. HCV seroprevalence of 5.8% was found, with HCV viraemia in 75% of the studied children. The prevalence of anti-HCV increased with age from 0% in children aged 6-7 years to 16% in those of 15 years old. It was also shown that history of previous blood transfusion (odds ratio[OR] = 34.8, 95% CI=4.39-272.95), intravenous injections (OR=4.68, 1.89-11.59), surgical intervention (OR=5.64, 2.55-12.52), dental treatment (OR = 6.81, 2.64-17.39), injection (OR=2.29, 1.08-4.89) and circumcision for boys by informal health care providers (OR=2.6, 1.0-6.73), age above 10 years (OR=6.83, 2.44-19.07), very low socioeconomic class (OR=5.92, 1.3-25.2) and rural area residence (OR=2.49,1.61-5.29) are the most significant risk factors for HCV infection. Adjusting for all other risk factors by multivariate logistic regression analysis, it has been shown that blood transfusion, surgical procedures, dental treatment, and age above 10 years are still significant risk factors associated with anti-HCV (P<0.05). The current study reveals the extremely high HCV seroprevalence among Egyptian children. This mandates immediate preventive strategies to limit further HCV spread.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21992795     DOI: 10.1111/j.1365-2893.2010.01381.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

1.  Risky exposures and national estimate of HCV seroprevalence among school children in urban Egypt.

Authors:  Ekram W Abd El-Wahab; Ahmed Abdel Maksoud; Hanan Z Shatat; Amira M Kotkat
Journal:  Virusdisease       Date:  2016-09-12

Review 2.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  Hepatitis C genotype 4: The past, present, and future.

Authors:  Tawhida Y Abdel-Ghaffar; Mostafa M Sira; Suzan El Naghi
Journal:  World J Hepatol       Date:  2015-12-08

Review 4.  Burden of pediatric hepatitis C.

Authors:  Mortada Hassan El-Shabrawi; Naglaa Mohamed Kamal
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

5.  CMV, B and C hepatitis among multi-transfused hereditary hemolytic Anemia children: an updated Egyptian experience.

Authors:  Laila M Sherief; Seham M Ragab; Mohamed A Helwa; Naglaa M Kamal; Mona R Afify; Rasha T S Mohammed; Ghada Abd Elmoniem Mokhtar; Hanan S Sherbiny
Journal:  Ital J Pediatr       Date:  2021-05-26       Impact factor: 2.638

6.  Low frequency of male circumcision and unwillingness to be circumcised among MSM in Buenos Aires, Argentina: association with sexually transmitted infections.

Authors:  María A Pando; Ivan C Balan; Curtis Dolezal; Ruben Marone; Victoria Barreda; Alex Carballo-Dieguez; María M Avila
Journal:  J Int AIDS Soc       Date:  2013-06-06       Impact factor: 5.396

Review 7.  The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis.

Authors:  Yousra A Mohamoud; Ghina R Mumtaz; Suzanne Riome; Dewolfe Miller; Laith J Abu-Raddad
Journal:  BMC Infect Dis       Date:  2013-06-24       Impact factor: 3.090

8.  Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents.

Authors:  Hanaa A El-Araby; Behairy E Behairy; Mohamed A El-Guindi; Nermin M Adawy; Alif A Allam; Ahmad M Sira; Mohamed A Khedr; Ibrahim A Elhenawy; Gihan A Sobhy; Hosam El Din M Basiouny; Menan E Salem; Samira A Abdel-Aziz; Ola A Fouad; Bassam A Ayoub
Journal:  Hepatol Int       Date:  2019-09-12       Impact factor: 9.029

Review 9.  Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.

Authors:  Silva P Kouyoumjian; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

10.  A cross-sectional household cluster serosurvey of hepatitis C virus antibodies in an urban slum of Cairo, Egypt in 2004.

Authors:  Isabelle A Nakhla; John W Sanders; Emad W Mohareb; Sahar Samy; Michael T Cosby; Manal M Mostafa; Mark S Riddle; Robert W Frenck
Journal:  Trop Dis Travel Med Vaccines       Date:  2015-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.